Used in research as a potent and selective inhibitor of phosphodiesterase 10A (PDE10A), this compound is valuable in studying neurological and psychiatric disorders such as schizophrenia, Huntington's disease, and other conditions involving dysregulation of the striatal signaling pathway. Its ability to modulate cAMP and cGMP levels in the brain makes it a tool compound for exploring intracellular signaling mechanisms. It is not used clinically but serves as a reference in pharmacological studies and drug development targeting PDE enzymes.